A Phase II Study of Sunitinib Malate (Sutent®) With Paclitaxel (Taxol®) in Patients With Advanced Esophageal Cancer

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

• J. M. Schmitt, S. R. Sommers, W. Fisher, R. Ansari, E. Robin, K. Koneru, J. McClean, Z. Liu, N. Hanna. Sunitinib plus Paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group: GI06-112. Accepted as abstract at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr e14661). See abstract.

Manuscripts/Articles:

• Jordan M. Schmitt, Scott R. Sommers, William Fisher, Rafat Ansari, Erwin Robin, Karuna Koneru, John McClean, Ziyue Liu, Nasser Hanna: Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group: GI06-112 J Thorac Oncol, 2012; 7: 760-763